Hypoxia induces an excitotoxic-type of dark cell degeneration in cerebellar Purkinje neurons

Neuroscience Research

Volumn 40, Issue 3, 2001, Pages 245-254

  Barenberg, Paul ^a   Strahlendorf, Howard ^a   Strahlendorf, Jean ^a  

^a TEXAS TECH UNIVERSITY   (United States)

Author keywords

AMPA; Apoptosis; Excitotoxicity; Hypoxia; Purkinje cells

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; CARBON DIOXIDE; DNA FRAGMENT; EXCITOTOXIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NITROGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN SLICE; CELL NUCLEUS; CELL VACUOLE; CEREBROSPINAL FLUID; CHROMATIN; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; FEMALE; GEL ELECTROPHORESIS; HYPOXIA; MALE; MORPHOLOGY; NERVE CELL DEGENERATION; NEWBORN; NICK END LABELING; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PURKINJE CELL; RAT; ULTRASTRUCTURE;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; CELL DEATH; CHROMATIN; DNA FRAGMENTATION; ELECTROPHORESIS, AGAR GEL; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HYPOXIA, BRAIN; IN SITU NICK-END LABELING; MALE; MICROSCOPY, ELECTRON; NERVE DEGENERATION; NEUROTOXINS; ORGAN CULTURE TECHNIQUES; ORGANELLES; PURKINJE CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0034937247     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-0102(01)00234-6     Document Type: Article

References (38)

1. Do NMDA antagonists prevent neuronal injury?
2. The AMPA antagonist NBQX protects against ischemic-induced loss of cerebellar Purkinje cells
3. Elevation of the extracellular concentration of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis
4. The excitotoxin hypothesis in relation to cerebral ischemia
5. The AMPA antagonist NBQX provides partial protection of rat cerebellar Purkinje cells after cardiac arrest and resuscitation
6. The expression of excitatory amino acid binding sits during neuritogenesis in the developing rat cerebellum
7. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage
8. Ultrastructural changes in the hippocampal CA1 region following transient cerebral ischemia: evidence against programmed cell death
9. Protein synthesis in the hippocampal slice: transient inhibition by glutamate and lasting inhibition by ischemia
10. Very delayed infarction after mild focal cerebral ischemia: a role for apoptosis?
11. Mechanisms of AMPA neurotoxicity in rat brain slices
12. AMPA neurotoxicity in rat cerebellar and hippocampal slices: histological evidence for three mechanisms
13. Posthypoxic treatment with MK-801 reduces hypoxic-ischemic damage in the neonatal rat
14. Delayed neuronal death and delayed neuronal recovery in the human brain following global ischemia
15. Pharmacologic blockade of non-NMDA receptors at deep prepiriform cortex attenuates heat shock protein expression in global ischemia
16. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics
17. Massive cerebral necrosis in newborn infants, its relation to maturation, its clinical and bioelectric symptoms
18. The changing landscape of ischaemic brain injury mechanisms
19. Apoptosis and protein expression after focal cerebral ischemia in rat
20. Evidence against a role for programmed cell death in focal cerebral ischemia in rats
21. Global ischemia can cause DNA fragmentation indicative of apoptosis in rat brain
22. MK-801 protects the neonatal brain from hypoxic ischemic damage
23. Systemic administration of MK-801 protects against N-methyl-D-asparate- and quisqualate-mediated neurotoxicity in perinatal rats
24. Postischemic blockade of AMPA but not NMDA receptors mitigrates neuronal damage in the rat brain following transient severe cerebral ischemia
25. The release and uptake of excitatory amino acids
26. Autoradiographic characterization and localization of quisqualate binding sites in rat brain using the antagonist [3H]6-cyano-(7-nitroquinoxaline-2,3-dione: comparison with (R,S)-[3H](-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid binding sites
27. Excitotoxic neuronal death in the immature brain is an apoptosis-necrosis morphological continuum
28. Temporal profile of neuronal damage in a model of transient forebrain ischemia
29. Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death
30. Glutamate and the pathophysiology of hypoxic-ischemic brain damage
31. Histological changes of neuronal damage in vegetative dogs induced by 18 min of complete global brain ischemia: two-phase damage of Purkinje cells and hippocampal CA1 pyramidal cells
32. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia
33. Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain
34. Inhibition of excitatory neurotransmission with kynurenate reduces brain edema in neonatal anoxia
35. Diazoxide and cyclothiazide convert AMPA-induced dark cell degeneration of Purkinje cells to edematous damage in the cerebellar slice
36. AMPA-elicited dark cell degeneration of cerebellar Purkinje neurons has characteristics of apoptosis
37. Apoptosis and necrosis in the newborn piglet brain following transient cerebral hypoxia-ischemia